scholarly journals S157 Medication Exposure and Impact of Cessation on the Long-Term Severity of Microscopic Colitis

2021 ◽  
Vol 116 (1) ◽  
pp. S69-S69
Author(s):  
Daniel B. Amusin ◽  
Iris Chiou ◽  
Eugene F. Yen
2020 ◽  
Vol 51 (6) ◽  
pp. 644-651 ◽  
Author(s):  
Mette Reilev ◽  
Jesper Hallas ◽  
Martin Thomsen Ernst ◽  
Gunnar Lauge Nielsen ◽  
Ole K. Bonderup

2021 ◽  
Vol 8 ◽  
Author(s):  
Poornima Oruganti ◽  
Rehmat Awan ◽  
Xianzhong Ding ◽  
Michael Wesolowski ◽  
Ayokunle T. Abegunde

Microscopic colitis (MC) is a common cause of chronic diarrhea with limited long-term data. We searched the pathology records at our institution from 2008 to 2018 to identify cases of MC. Total sample included patients with either a diagnosis of MC or incomplete MC (MCi).Chart review was performed and data were summarized for descriptive statistics. Logistic regression was used to estimate the unadjusted effects of predictors on MC. A total of 216 patients (88.32% white, 80.56% females, mean age 67.12 +/– 15.79) were studied; 50.00% had CC, 40.28% had LC and 9.72% had MCi. Majority (52.31%) were smokers and 21.84% of females were using some form of hormonal therapy. The odds of LC in reference to CC were significantly higher for those using tricyclic antidepressants (TCAs) (OR: 3.23, 95% C.I: 1.18–8.80, p = 0.02). The odds of smoking, statins, aspirin and beta-blocker use were decreased in MCi in reference to CC (all p < 0.05), 29 (74.35%) patients with unresolved symptoms underwent repeat colonoscopies with biopsies. One case of MCi resolved, 8 (72.73%) out of 11 cases of LC resolved, 2 (18.18%) continued to be LC and 1 (9.09%) transformed to CC, 8 (47.06%) out of 17 cases of CC resolved, 8 (47.06%) continued to be CC and 1 (5.88%) transformed to LC. Majority of patients had CC. TCA use resulted in increased odds of LC in reference to CC. Biopsies from repeat colonoscopies in some patients revealed changes in the pathological diagnoses raising the question of interchangeability of MC (CC to LC and vice versa).


2019 ◽  
Vol 10 (9) ◽  
pp. e00071 ◽  
Author(s):  
Julien Loreau ◽  
Dana Duricova ◽  
Corinne Gower-Rousseau ◽  
Guillaume Savoye ◽  
Olivier Ganry ◽  
...  

Author(s):  
Lærke Müller Olsen ◽  
Peter Johan Heiberg Engel ◽  
Danny Goudkade ◽  
Vincenzo Villanacci ◽  
Jeppe Thagaard ◽  
...  

2015 ◽  
Vol 33 (2) ◽  
pp. 208-214 ◽  
Author(s):  
Gerd Bouma ◽  
Andreas Münch

Microscopic colitis (MC) is the common denominator for lymphocytic and collagenous colitis (CC). It is now recognized as a relatively frequent cause of diarrhea that equals the prevalence of inflammatory bowel disease. Patients are typically middle-aged women, but disease may occur at every age. Patients with MC report watery, non-bloody diarrhea in the absence of endoscopic and radiologic abnormalities. Lymphocytic colitis is characterized by an increased number of intraepithelial lymphocytes, and CC by a thickened subepithelial collagen band, whereas in both an increased mononuclear infiltration of the lamina propria is found. The pathogenesis of MC is largely unknown, but may relate to autoimmunity, adverse reactions to drugs or (bacterial) toxins, and abnormal collagen metabolism in the case of CC. Budesonide is so far the only drug that has proven efficacy in randomized controlled trials both for the induction and maintenance of remission. Patients who are nonresponsive, dependent or who experience side effects on budesonide may benefit from thiopurine or anti-TNF treatment, but these options are still experimental. The long-term prognosis of MC is good; it does not appear to predispose to malignancies and can in some cases be self-limiting. Further research and randomized clinical trials are required to expand our understanding of the natural course and the pathogenesis of MC.


Sign in / Sign up

Export Citation Format

Share Document